Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SARNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PITPNM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBPMS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUGP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD50 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POM121L9P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
B3GLCT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
C8orf22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927166 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GART - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSBP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF83 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCHSD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM210A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on